SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950134-07-013521
Filing Date
2007-06-18
Accepted
2007-06-18 06:05:44
Documents
4
Period of Report
2007-06-13
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K v31045e8vk.htm 8-K 26652
2 EXHIBIT 10.1 v31045exv10w1.htm EX-10.1 18714
3 EXHIBIT 99.1 v31045exv99w1.htm EX-99.1 2679
4 GRAPHIC v31045v3104500.gif GRAPHIC 14127
  Complete submission text file 0000950134-07-013521.txt   69416
Mailing Address 18701 120TH AVENUE NE SUITE 100 BOTHELL WA 98011
Business Address 18701 120TH AVENUE NE SUITE 100 BOTHELL WA 98011 4256083008
NORTHWEST BIOTHERAPEUTICS INC (Filer) CIK: 0001072379 (see all company filings)

IRS No.: 943306718 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-33393 | Film No.: 07924528
SIC: 2834 Pharmaceutical Preparations